With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union agency EDCTP approved for funding another new project: “LiberHetica: increasing the ethics capacity of oversight for clinical trials in Liberia by establishing European-African collaborations that facilitates implementation of efficient processes …”. A great team lead by Liberian institutional rapresentatives made this come true, therefore I would like to thank Dr. Bolay Fotorma, Jemee Tegli, Dr. Stephen B. Kennedy, Gloria Mason, and Cecilia Morris.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Ebola vaccines at a la glance

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

SUPER

The SUPER project will provide capacity building at the regulatory and ethics level for National Regulatory Authority, National and Institutional Ethics Committees, with the ultimate goal to strengthen an environement

EVD68-VAXREADY: A decisive step forward for European epidemic preparedness and viral emergency response

Emerging and re-emerging viral infections represent one of the most complex challenges for global public health. Among these, Enterovirus D68 (EV-D68) is emerging with increasing urgency due to recurring outbreaks